Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer

Showing results (421-430 of 41,513) with videos related to

Pageof 4,152
Sort By:
Cancer|August 9, 2016
Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumorsSarah C Markt, Carlos A Lago-Hernandez, Rowan E Miller, et al.
Cancer|August 3, 2016
Second malignancy risk among pediatric, adolescent, and young adult survivors of fusion-positive and fusion-negative sarcomas: Results from the SEER database, 1992 through 2012Philip J Lupo, Austin L Brown, Simone Hettmer
Cancer|July 22, 2016
Arsenic in private well water may contribute to bladder cancer riskCarrie Printz
Cancer|July 20, 2016
Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk menAubrey R Turner, Brian R Lane, Dan Rogers, et al.
Cancer|July 20, 2016
A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myelomaAjai Chari, Myo Htut, Jeffrey A Zonder, et al.
Cancer|July 20, 2016
Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapyJian Ji Pan, Wai Tong Ng, Jing Feng Zong, et al.
Cancer|May 7, 2015
Business as usual is not acceptableK Michael Cummings, James W Gustafson, David J Sales, et al.
Cancer|April 24, 2015
Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United StatesSarah S Mougalian, Pamela R Soulos, Brigid K Killelea, et al.
Cancer|April 24, 2015
Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancerRana R McKay, Kathryn P Gray, Julia H Hayes, et al.
Cancer|April 24, 2015
Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinomaGaya Spolverato, Mohammad Y Yakoob, Yuhree Kim, et al.
Pageof 4,152

Showing results (421-430 of 41,513) with videos related to

Sort By:
Pageof 4,152
Cancer|August 9, 2016
Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumorsSarah C Markt, Carlos A Lago-Hernandez, Rowan E Miller, et al.
Cancer|August 3, 2016
Second malignancy risk among pediatric, adolescent, and young adult survivors of fusion-positive and fusion-negative sarcomas: Results from the SEER database, 1992 through 2012Philip J Lupo, Austin L Brown, Simone Hettmer
Cancer|July 22, 2016
Arsenic in private well water may contribute to bladder cancer riskCarrie Printz
Cancer|July 20, 2016
Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk menAubrey R Turner, Brian R Lane, Dan Rogers, et al.
Cancer|July 20, 2016
A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myelomaAjai Chari, Myo Htut, Jeffrey A Zonder, et al.
Cancer|July 20, 2016
Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapyJian Ji Pan, Wai Tong Ng, Jing Feng Zong, et al.
Cancer|May 7, 2015
Business as usual is not acceptableK Michael Cummings, James W Gustafson, David J Sales, et al.
Cancer|April 24, 2015
Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United StatesSarah S Mougalian, Pamela R Soulos, Brigid K Killelea, et al.
Cancer|April 24, 2015
Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancerRana R McKay, Kathryn P Gray, Julia H Hayes, et al.
Cancer|April 24, 2015
Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinomaGaya Spolverato, Mohammad Y Yakoob, Yuhree Kim, et al.
Pageof 4,152